Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FX1JZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,049
Award facts
- Contract value 100% obligated
- $17,048.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,048.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. This delivery order, issued on October 17, 2025, with an ultimate completion date of November 7, 2025, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. DMS Pharmaceutical Group operates as a critical supplier within the Department of Defense pharmaceutical supply chain, leveraging its small business status and established market position to compete effectively across diverse product categories.
This delivery order falls under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The parent contract, valued at $499.9 million with a completion date of December 31, 2036, authorizes the company to supply a comprehensive range of pharmaceuticals and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide. The IDC structure enables the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical devices, with DMS Pharmaceutical Group positioned as one of multiple regional prime vendor contractors supporting global Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FX1JZ?
SPE2DB26FX1JZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FX1JZ worth?
The government has obligated $17,049 on SPE2DB26FX1JZ.
Is contract SPE2DB26FX1JZ an order under another contract?
Yes. SPE2DB26FX1JZ is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1JZ competed?
The extent of competition for SPE2DB26FX1JZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award